ALZAI Health Corp. Posted for Trading On The Frankfurt Stock Exchange

ALZAI Health Corp. Announces Marketing Services Agreement

ALZAI and Linus Health explore AI-driven collaborations aimed at early identification of Alzheimer’s disease risk and cognitive impairment

ALZAI Health Corp. Secures Exclusive Global License for AI-Driven Liver Disease Risk Identification Technology

ALZAI HEALTH CORP. ANNOUNCES VALIDATION OF ITS AI-DRIVEN ALZHEIMERS DISEASE RISK SCREENING SOLUTION ON LARGE-SCALE U.S. PATIENT DATA

ALZAI HEALTH CORP. SIGNS STRATEGIC U.S. COMMERCIALIZATION AGREEMENT WITH CENTAURI HEALTH SOLUTIONS TO ADVANCE AI-DRIVEN ALZHEIMER’S RISK IDENTIFICATION